Abstract
More than half of all proteins are glycosylated. The attached glycans provide proteins with important structural and functional properties and glycan parts of glycoproteins have essential roles in many key biological processes. This chapter describes the effect of glycosylation on the structure and function of proteins, with emphasis on regulation of protein half-life and modulation of protein function by alternative glycosylation. In addition, this chapter highlights the importance of glycan–lectin interactions, the ability of glycans to block phosphorylation of proteins, and the importance of glycans in disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Apweiler R, Hermjakob H, Sharon N (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473:4-8
Roth J (2002) Protein N-Glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 102:285–304
Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435–471
Cummings RD (2009) The repertoire of glycan determinants in the human glycome. Mol Biosyst 5:1087–1104
Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3:97-130.
Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126:855–867
Krištić J, Zoldoš V, Lauc G (2014) Complex genetics of protein N-glycosylation. In: Endo T, Seeberger PH, Hart GW, Wong CH, Taniguchi N (eds) Glycoscience: biology and medicine. Springer, Japan
Varki A (2011) Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells. Cold Spring Harb Perspect Biol 3:a005462
Vogel J, Sperandio M, Pries AR, Linderkamp O, Gaehtgens P, Kuschinsky W (2000) Influence of the endothelial glycocalyx on cerebral blood flow in mice. J Cereb Blood Flow Metab 20:1571–1578
Cohen M (2015) Notable aspects of glycan-protein interactions. Biomolecules 5:2056–2072
Varki A, Etzler ME, Cummings RD et al (2009) Discovery and classification of glycan-binding proteins. In: Varki A, Cummings RD, Esko JD et al (eds). Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York. http://www.ncbi.nlm.nih.gov/books/NBK1923/
Cummings RD, Esko JD (2009) Principles of glycan recognition. In: Varki A, Cummings RD, Esko JD et al (eds). Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York. http://www.ncbi.nlm.nih.gov/books/NBK1950/
Nagae M, Yamaguchi Y (2015) Sugar recognition and protein-protein interaction of mammalian lectins conferring diverse functions. Curr Opin Struct Biol 34:108–115
Bochner BS, Zimmermann N (2015) Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. J Allergy Clin Immunol 135:598–608
Sperandio M, Gleissner CA, Ley K (2009) Glycosylation in immune cell trafficking. Immunology 230:97–113
Hirakawa J, Tsuboi K, Sato K, Kobayashi M, Watanabe S, Takakura A, Imai Y, Ito Y, Fukuda M, Kawashima H (2010) Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing. J Biol Chem 285:40864–40878
Diekman AB (2003) Glycoconjugates in sperm function and gamete interactions: how much sugar does it take to sweet-talk the egg? Cell Mol Life Sci 60:298-308
Pang PC, Chiu PC, Lee CL, Chang LY, Panico M, Morris HR, Haslam SM, Khoo KH, Clark GF, Yeung WS, Dell A (2011) Human sperm binding is mediated by the Sialyl-Lewis(x) oligosaccharide on the zona pellucida. Science 333:1761–1764
Suzuki Y (2005) Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 28:399–408
Hu l, Crawford SE, Czako R, Cortes-Penfield NW, Smith DF, Le Pendu J, Estes MK, Prasad BV (2012) Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485:256-259
Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl J Med 361:1776–1785
Shukla D, Spear PG (2001) Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest 108:503–510
Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Borén T (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373–377
Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306:120–124
Wide L, Eriksson K, Sluss PM, Hall JE (2009) Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women. J Clin Endocrinol Metab 94:958–964
Becker V, Timmer J, Klingmüller U (2012) Receptor dynamics in signaling. Adv Exp Med Biol 736:313–323
Lo WY, Lagrange AH, Hernandez CC, Harrison R, Dell A, Haslam SM, Sheehan JH, Macdonald RL (2010) Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating. J Biol Chem 285:31348–31361
Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD (2005) Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123:1307–1321
Wide L, Naessén T, Sundström-Poromaa I, Eriksson K (2007) Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men. J Clin Endocrinol Metab 92:4410–4417
Mi Y, Lin A, Fiete D, Steirer L, Baenziger JU (2014) Modulation of mannose and asialoglycoprotein receptor expression determines glycoprotein hormone half-life at critical points in the reproductive cycle. J Biol Chem 289:12157–12167
Egrie JC, Browne JK (2001) Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 84:3–10
Byrne B, Donohoe GG, O’Kennedy R (2007) Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today 12:319–326
Jeong YT, Choi O, Lim HR, Son YD, Kim HJ, Kim JH (2008) Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. J Microbiol Biotechnol 18:1945–1952
Su D, Zhao H, Xia H (2010) Glycosylation-modified erythropoietin with improved half-life and biological activity. Int J Hematol 91:238–244
Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284:770–776
Bolós V1, Grego-Bessa J, de la Pompa JL (2007) Notch signaling in development and cancer. Endocr Rev 28:339-363
Stanley P (2007) Regulation of Notch signaling by glycosylation. Curr Opin Struct Biol 17:530–535
Hicks C, Johnston SH, diSibio G, Collazo A, Vogt TF, Weinmaster G (2000) Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol 2:515–520
Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, Weinmaster G (2005) Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol Biol Cell 16:927–942
Taylor P, Takeuchi H, Sheppard D, Chillakuri C, Lea SM, Haltiwanger RS, Handford PA (2014) Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands. Proc Natl Acad Sci U S A 111:7290–7295
Boareto M, Jolly MK, Lu M, Onuchic JN, Clementi C, Ben-Jacob E (2015) Jagged–Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype. Proc Natl Acad Sci U S A 112:E402–E409
Schwab I and Nimmerjahn F (2013) Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13:176-189
Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, vol 313. Science, pp. 670–673
Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A, Yokoi H, Nakamura K, Shitara K (2004) Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of Fcgamma RIIIa functional polymorphism. Clin Cancer Res 10:6248–6255
Iida S, Misaka H, Inoue M, Shibata M, Nakano R, Yamane-Ohnuki N, Wakitani M, Yano K, Shitara K, Satoh M (2006) Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa. Clin Cancer Res 12:2879–2887
Masuda K, Kubota T, Kaneko E, Iida S, Wakitani M, Kobayashi-Natsume Y, Kubota A, Shitara K, Nakamura K (2007) Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol 44:3122–3131
Hart GW, Akimoto Y. The O-GlcNAc modification (2009) In: Varki A, Cummings RD, Esko JD et al (eds). Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York. http://www.ncbi.nlm.nih.gov/books/NBK1954/
Hayes BK, Hart GW (1998) Protein O-GlcNAcylation: potential mechanisms for the regulation of protein function. In: Axford JS (ed) Glycoimmunology, Advances in experimental medicine and biology, vol vol 435, 2 edn. Springer, New York, pp. 85–94
Slawson C, Hart GW (2003) Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation. Curr Opin Struct Biol 13:631–636
Zeidan Q, Hart GW (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123:13–22
Cohen P (2000) The regulation of protein function by multisite phosphorylation—a 25 year update. Trends Biochem Sci 25:596–601
Whelan SA, Hart GW (2003) Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93:1047–1058
Hardivillé S, Hart GW (2014) Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab 20:208–213
Lewis BA (2013) O-GlcNAcylation at promoters, nutrient sensors, and transcriptional regulation. Biochim Biophys Acta 1829:1202-1206
Comer FI, Hart GW (2000) O-Glycosylation of nuclear and cytosolic proteins: DYNAMIC INTERPLAY BETWEEN O-GlcNAc ANDO-PHOSPHATE. J Biol Chem 275:29179–29182
Hanover JA (2001) Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15:1865–1876
Bond MR, Hanover JA (2015) A little sugar goes a long way: the cell biology of O-GlcNAc. J Cell Biol 208:869–880
Shafi R, Iyer SP, Ellies LG, O’Donnell N, Marek KW, Chui D, Hart GW, Marth JD (2000) The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 97:5735–5739
Marek KW, Vijay IK, Marth JD (1999) A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology 9:1263–1271
Freeze HH (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology 11:129R-143R
Lauc G, Pezer M, Rudan I, Campbell H (2015) Mechanisms of disease: the human N-glycome. Biochim Biophys Acta. doi:10.1016/j.bbagen.2015.10.016
Stowell SR, Ju T, Cummings RD (2015) Protein glycosylation in cancer. Annu Rev Pathol 10:473–510
Thanabalasingham G, Huffman JE, Kattla JJ, Novokmet M, Rudan I, Gloyn AL, Hayward C, Adamczyk B, Reynolds RM, Muzinic A, et al. (2013) Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes 62:1329–1337
Vučković F, Krištić J, Gudelj 1, Teruel M, Keser T, Pezer M, Pučić-Baković M, Štambuk J, Trbojević-Akmačić I, Barrios C et al (2015) Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol 67:2978-2989
Trbojević Akmačić I, Ventham NT, Theodoratou E, Vučković F, Kennedy NA, Krištić J, Nimmo ER, Kalla R, Drummond H, Štambuk J, et al. (2015) Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm Bowel Dis 21:1237–1247
Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, D. Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452-457
Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J (2010) Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev 29:79-125
Kreisman LS, Cobb BA (2012) Infection, inflammation and host carbohydrates: a Glyco-Evasion hypothesis. Glycobiology 22:1019–1030
Huffman JE, Pučić-Baković M, Klarić L, Hennig R, Selman MH, Vučković F, Novokmet M, Krištić J, Borowiak M, Muth T, et al. (2014) Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13:1598–1610
Zoldos V, Horvat T, Lauc G (2013) Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies. Curr Opin Chem Biol 17:34-40
Taniguchi N, Kizuka Y (2015) Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res 126:11–51
Drake PM, Cho W, Li B, Prakobphol A, Johansen E, Anderson NL, Regnier FE, Gibson BW, Fisher SJ (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56:223–236
Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5:526–542
Dube DH, Bertozzi CR (2005) Glycans in cancer and inflammation–potential for therapeutics and diagnostics. Nat Rev Drug Discov 4:477–488
Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, Gornik O, Supraha-Goreta S, Wormald MR, Redzic I, et al. (2011) High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10:M111 010090
Knežević A, Polašek O, Gornik O, Rudan I, Campbell H, Hayward C, Wright A, Kolčić I, O’Donoghue N, Bones J, et al. (2009) Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res 8:694–701
Ogata S, Shimizu C, Franco A, Touma R, Kanegaye JT, Choudhury BP, Naidu NN, Kanda Y, Hoang LT, Hibberd ML, Tremoulet AH, Varki A, Burns JC (2013) Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS One 8:e81448
Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE, Scherer HU (2013) Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-203565
Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G (2013) Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest 123:2183–2192
Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, O’Donnell CI, Derber LA, Weinblatt ME, Shadick NA, Bell DA, Cairns E, Solomon DH, Holers VM, Rudd PM, Lee DM (2010) Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 62:2239–2248
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Krištić, J., Lauc, G. (2017). Ubiquitous Importance of Protein Glycosylation. In: Lauc, G., Wuhrer, M. (eds) High-Throughput Glycomics and Glycoproteomics. Methods in Molecular Biology, vol 1503. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6493-2_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6493-2_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6491-8
Online ISBN: 978-1-4939-6493-2
eBook Packages: Springer Protocols